| Year |
Citation |
Score |
| 2018 |
Desmonde S, Tanser F, Vreeman R, Takassi E, Edmonds A, Lumbiganon P, Pinto J, Malateste K, McGowan C, Kariminia A, Yotebieng M, Dicko F, Yiannoutsos C, Mubiana-Mbewe M, Wools-Kaloustian K, et al. Access to antiretroviral therapy in HIV-infected children aged 0-19 years in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Global Cohort Consortium, 2004-2015: A prospective cohort study. Plos Medicine. 15: e1002565. PMID 29727458 DOI: 10.1371/Journal.Pmed.1002565 |
0.351 |
|
| 2018 |
Tymejczyk O, Brazier E, Yiannoutsos C, Wools-Kaloustian K, Althoff K, Crabtree-Ramírez B, Van Nguyen K, Zaniewski E, Dabis F, Sinayobye JD, Anderegg N, Ford N, Wikramanayake R, Nash D. HIV treatment eligibility expansion and timely antiretroviral treatment initiation following enrollment in HIV care: A metaregression analysis of programmatic data from 22 countries. Plos Medicine. 15: e1002534. PMID 29570723 DOI: 10.1371/Journal.Pmed.1002534 |
0.303 |
|
| 2018 |
Vreeman RC, Ayaya SO, Musick BS, Yiannoutsos CT, Cohen CR, Nash D, Wabwire D, Wools-Kaloustian K, Wiehe SE. Adherence to antiretroviral therapy in a clinical cohort of HIV-infected children in East Africa. Plos One. 13: e0191848. PMID 29466385 DOI: 10.1371/Journal.Pone.0191848 |
0.339 |
|
| 2017 |
Anderegg N, Johnson LF, Zaniewski E, Althoff KN, Balestre E, Law M, Nash D, Shepherd BE, Yiannoutsos CT, Egger M. All-cause mortality in HIV-positive adults starting combination antiretroviral therapy: correcting for loss to follow-up. Aids (London, England). 31: S31-S40. PMID 28296798 DOI: 10.1097/Qad.0000000000001321 |
0.305 |
|
| 2015 |
Geng EH, Odeny TA, Lyamuya RE, Nakiwogga-Muwanga A, Diero L, Bwana M, Muyindike W, Braitstein P, Somi GR, Kambugu A, Bukusi EA, Wenger M, Wools-Kaloustian KK, Glidden DV, Yiannoutsos CT, et al. Estimation of Mortality among HIV-infected people on antiretroviral therapy treatment in east Africa: a sampling based approach in an observational, multisite, cohort study. The Lancet Hiv. 2: e107-e116. PMID 26120593 DOI: 10.1016/S2352-3018(15)00002-8 |
0.317 |
|
| 2015 |
Anderson AM, Harezlak J, Bharti A, Mi D, Taylor MJ, Daar ES, Schifitto G, Zhong J, Alger JR, Brown MS, Singer EJ, Campbell TB, McMahon DD, Buchthal S, Cohen R, ... Yiannoutsos C, et al. Plasma and Cerebrospinal Fluid Biomarkers Predict Cerebral Injury in HIV-Infected Individuals on Stable Combination Antiretroviral Therapy. Journal of Acquired Immune Deficiency Syndromes (1999). 69: 29-35. PMID 25622053 DOI: 10.1097/Qai.0000000000000532 |
0.376 |
|
| 2014 |
Peterson J, Gisslen M, Zetterberg H, Fuchs D, Shacklett BL, Hagberg L, Yiannoutsos CT, Spudich SS, Price RW. Cerebrospinal fluid (CSF) neuronal biomarkers across the spectrum of HIV infection: hierarchy of injury and detection. Plos One. 9: e116081. PMID 25541953 DOI: 10.1371/Journal.Pone.0116081 |
0.332 |
|
| 2014 |
Young AC, Yiannoutsos CT, Hegde M, Lee E, Peterson J, Walter R, Price RW, Meyerhoff DJ, Spudich S. Cerebral metabolite changes prior to and after antiretroviral therapy in primary HIV infection. Neurology. 83: 1592-600. PMID 25261502 DOI: 10.1212/Wnl.0000000000000932 |
0.375 |
|
| 2014 |
Petersen M, Yiannoutsos CT, Justice A, Egger M. Observational research on NCDs in HIV-positive populations: conceptual and methodological considerations. Journal of Acquired Immune Deficiency Syndromes (1999). 67: S8-16. PMID 25117964 DOI: 10.1097/Qai.0000000000000253 |
0.338 |
|
| 2014 |
Petersen ML, Tran L, Geng EH, Reynolds SJ, Kambugu A, Wood R, Bangsberg DR, Yiannoutsos CT, Deeks SG, Martin JN. Delayed switch of antiretroviral therapy after virologic failure associated with elevated mortality among HIV-infected adults in Africa. Aids (London, England). 28: 2097-107. PMID 24977440 DOI: 10.1097/Qad.0000000000000349 |
0.307 |
|
| 2014 |
Harezlak J, Cohen R, Gongvatana A, Taylor M, Buchthal S, Schifitto G, Zhong J, Daar ES, Alger JR, Brown M, Singer EJ, Campbell TB, McMahon D, So YT, Yiannoutsos CT, et al. Predictors of CNS injury as measured by proton magnetic resonance spectroscopy in the setting of chronic HIV infection and CART. Journal of Neurovirology. 20: 294-303. PMID 24696364 DOI: 10.1007/S13365-014-0246-6 |
0.426 |
|
| 2014 |
Gold JA, Grill M, Peterson J, Pilcher C, Lee E, Hecht FM, Fuchs D, Yiannoutsos CT, Price RW, Robertson K, Spudich S. Longitudinal characterization of depression and mood states beginning in primary HIV infection. Aids and Behavior. 18: 1124-32. PMID 24385231 DOI: 10.1007/S10461-013-0688-5 |
0.337 |
|
| 2013 |
Hua X, Boyle CP, Harezlak J, Tate DF, Yiannoutsos CT, Cohen R, Schifitto G, Gongvatana A, Zhong J, Zhu T, Taylor MJ, Campbell TB, Daar ES, Alger JR, Singer E, et al. Disrupted cerebral metabolite levels and lower nadir CD4 + counts are linked to brain volume deficits in 210 HIV-infected patients on stable treatment. Neuroimage. Clinical. 3: 132-42. PMID 24179857 DOI: 10.1016/J.Nicl.2013.07.009 |
0.416 |
|
| 2013 |
Yilmaz A, Yiannoutsos CT, Fuchs D, Price RW, Crozier K, Hagberg L, Spudich S, Gisslén M. Cerebrospinal fluid neopterin decay characteristics after initiation of antiretroviral therapy. Journal of Neuroinflammation. 10: 62. PMID 23664008 DOI: 10.1186/1742-2094-10-62 |
0.314 |
|
| 2013 |
Gongvatana A, Harezlak J, Buchthal S, Daar E, Schifitto G, Campbell T, Taylor M, Singer E, Algers J, Zhong J, Brown M, McMahon D, So YT, Mi D, Heaton R, ... ... Yiannoutsos C, et al. Progressive cerebral injury in the setting of chronic HIV infection and antiretroviral therapy. Journal of Neurovirology. 19: 209-18. PMID 23613008 DOI: 10.1007/S13365-013-0162-1 |
0.443 |
|
| 2013 |
Geng EH, Bwana MB, Muyindike W, Glidden DV, Bangsberg DR, Neilands TB, Bernheimer I, Musinguzi N, Yiannoutsos CT, Martin JN. Failure to initiate antiretroviral therapy, loss to follow-up and mortality among HIV-infected patients during the pre-ART period in Uganda. Journal of Acquired Immune Deficiency Syndromes (1999). 63: e64-71. PMID 23429504 DOI: 10.1097/QAI.0b013e31828af5a6 |
0.308 |
|
| 2013 |
Gelman BB, Lisinicchia JG, Morgello S, Masliah E, Commins D, Achim CL, Fox HS, Kolson DL, Grant I, Singer E, Yiannoutsos CT, Sherman S, Gensler G, Moore DJ, Chen T, et al. Neurovirological correlation with HIV-associated neurocognitive disorders and encephalitis in a HAART-era cohort. Journal of Acquired Immune Deficiency Syndromes (1999). 62: 487-95. PMID 23242157 DOI: 10.1097/Qai.0B013E31827F1Bdb |
0.356 |
|
| 2012 |
Yiannoutsos CT, Johnson LF, Boulle A, Musick BS, Gsponer T, Balestre E, Law M, Shepherd BE, Egger M. Estimated mortality of adult HIV-infected patients starting treatment with combination antiretroviral therapy. Sexually Transmitted Infections. 88: i33-43. PMID 23172344 DOI: 10.1136/sextrans-2012-050658 |
0.314 |
|
| 2011 |
Geng EH, Hunt PW, Diero LO, Kimaiyo S, Somi GR, Okong P, Bangsberg DR, Bwana MB, Cohen CR, Otieno JA, Wabwire D, Elul B, Nash D, Easterbrook PJ, Braitstein P, ... ... Yiannoutsos CT, et al. Trends in the clinical characteristics of HIV-infected patients initiating antiretroviral therapy in Kenya, Uganda and Tanzania between 2002 and 2009. Journal of the International Aids Society. 14: 46. PMID 21955541 DOI: 10.1186/1758-2652-14-46 |
0.328 |
|
| 2011 |
Braithwaite RS, Nucifora KA, Yiannoutsos CT, Musick B, Kimaiyo S, Diero L, Bacon MC, Wools-Kaloustian K. Alternative antiretroviral monitoring strategies for HIV-infected patients in east Africa: opportunities to save more lives? Journal of the International Aids Society. 14: 38. PMID 21801434 DOI: 10.1186/1758-2652-14-38 |
0.334 |
|
| 2011 |
Tate DF, Sampat M, Harezlak J, Fiecas M, Hogan J, Dewey J, McCaffrey D, Branson D, Russell T, Conley J, Taylor M, Schifitto G, Schifitto G, Zhong J, Daar ES, ... ... Yiannoutsos C, et al. Regional areas and widths of the midsagittal corpus callosum among HIV-infected patients on stable antiretroviral therapies. Journal of Neurovirology. 17: 368-79. PMID 21556960 DOI: 10.1007/S13365-011-0033-6 |
0.418 |
|
| 2011 |
Braitstein P, Songok J, Vreeman RC, Wools-Kaloustian KK, Koskei P, Walusuna L, Ayaya S, Nyandiko W, Yiannoutsos C. "Wamepotea" (they have become lost): outcomes of HIV-positive and HIV-exposed children lost to follow-up from a large HIV treatment program in western Kenya. Journal of Acquired Immune Deficiency Syndromes (1999). 57: e40-6. PMID 21407085 DOI: 10.1097/QAI.0b013e3182167f0d |
0.308 |
|
| 2011 |
Harezlak J, Buchthal S, Taylor M, Schifitto G, Zhong J, Daar E, Alger J, Singer E, Campbell T, Yiannoutsos C, Cohen R, Navia B. Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment. Aids (London, England). 25: 625-33. PMID 21297425 DOI: 10.1097/Qad.0B013E3283427Da7 |
0.356 |
|
| 2011 |
Letendre SL, Zheng JC, Kaul M, Yiannoutsos CT, Ellis RJ, Taylor MJ, Marquie-Beck J, Navia B. Chemokines in cerebrospinal fluid correlate with cerebral metabolite patterns in HIV-infected individuals. Journal of Neurovirology. 17: 63-9. PMID 21246320 DOI: 10.1007/S13365-010-0013-2 |
0.423 |
|
| 2010 |
Siika AM, Wools-Kaloustian K, Mwangi AW, Kimaiyo SN, Diero LO, Ayuo PO, Owino-Ong'or WD, Sidle JE, Einterz RM, Yiannoutsos CT, Musick B, Tierney WM. Risk factors for death in HIV-infected adult African patients receiving anti-retroviral therapy. East African Medical Journal. 87: 443-51. PMID 23457806 |
0.308 |
|
| 2010 |
Cohen RA, Harezlak J, Gongvatana A, Buchthal S, Schifitto G, Clark U, Paul R, Taylor M, Thompson P, Tate D, Alger J, Brown M, Zhong J, Campbell T, Singer E, ... ... Yiannoutsos CT, et al. Cerebral metabolite abnormalities in human immunodeficiency virus are associated with cortical and subcortical volumes. Journal of Neurovirology. 16: 435-44. PMID 20961212 DOI: 10.3109/13550284.2010.520817 |
0.4 |
|
| 2010 |
Ochieng-Ooko V, Ochieng D, Sidle JE, Holdsworth M, Wools-Kaloustian K, Siika AM, Yiannoutsos CT, Owiti M, Kimaiyo S, Braitstein P. Influence of gender on loss to follow-up in a large HIV treatment programme in western Kenya. Bulletin of the World Health Organization. 88: 681-8. PMID 20865073 DOI: 10.2471/BLT.09.064329 |
0.311 |
|
| 2010 |
Geng EH, Glidden DV, Emenyonu N, Musinguzi N, Bwana MB, Neilands TB, Muyindike W, Yiannoutsos CT, Deeks SG, Bangsberg DR, Martin JN. Tracking a sample of patients lost to follow-up has a major impact on understanding determinants of survival in HIV-infected patients on antiretroviral therapy in Africa. Tropical Medicine & International Health : Tm & Ih. 15: 63-9. PMID 20586962 DOI: 10.1111/J.1365-3156.2010.02507.X |
0.311 |
|
| 2010 |
Braitstein P, Katshcke A, Shen C, Sang E, Nyandiko W, Ochieng VO, Vreeman R, Yiannoutsos CT, Wools-Kaloustian K, Ayaya S. Retention of HIV-infected and HIV-exposed children in a comprehensive HIV clinical care programme in Western Kenya. Tropical Medicine & International Health : Tm & Ih. 15: 833-41. PMID 20487430 DOI: 10.1111/j.1365-3156.2010.02539.x |
0.361 |
|
| 2010 |
Cohen RA, Harezlak J, Schifitto G, Hana G, Clark U, Gongvatana A, Paul R, Taylor M, Thompson P, Alger J, Brown M, Zhong J, Campbell T, Singer E, Daar E, ... ... Yiannoutsos CT, et al. Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era. Journal of Neurovirology. 16: 25-32. PMID 20113183 DOI: 10.3109/13550280903552420 |
0.405 |
|
| 2009 |
Schifitto G, Yiannoutsos CT, Ernst T, Navia BA, Nath A, Sacktor N, Anderson C, Marra CM, Clifford DB. Selegiline and oxidative stress in HIV-associated cognitive impairment. Neurology. 73: 1975-81. PMID 19890073 DOI: 10.1212/Wnl.0B013E3181C51A48 |
0.317 |
|
| 2008 |
Paul RH, Ernst T, Brickman AM, Yiannoutsos CT, Tate DF, Cohen RA, Navia BA. Relative sensitivity of magnetic resonance spectroscopy and quantitative magnetic resonance imaging to cognitive function among nondemented individuals infected with HIV. Journal of the International Neuropsychological Society : Jins. 14: 725-33. PMID 18764968 DOI: 10.1017/S1355617708080910 |
0.439 |
|
| 2008 |
Yiannoutsos CT, Nakas CT, Navia BA. Assessing multiple-group diagnostic problems with multi-dimensional receiver operating characteristic surfaces: application to proton MR Spectroscopy (MRS) in HIV-related neurological injury. Neuroimage. 40: 248-55. PMID 18191586 DOI: 10.1016/J.Neuroimage.2007.09.056 |
0.416 |
|
| 2007 |
Paul RH, Yiannoutsos CT, Miller EN, Chang L, Marra CM, Schifitto G, Ernst T, Singer E, Richards T, Jarvik GJ, Price R, Meyerhoff DJ, Kolson D, Ellis RJ, Gonzalez G, et al. Proton MRS and neuropsychological correlates in AIDS dementia complex: evidence of subcortical specificity. The Journal of Neuropsychiatry and Clinical Neurosciences. 19: 283-92. PMID 17827413 DOI: 10.1176/Appi.Neuropsych.19.3.283 |
0.508 |
|
| 2007 |
Schifitto G, Navia BA, Yiannoutsos CT, Marra CM, Chang L, Ernst T, Jarvik JG, Miller EN, Singer EJ, Ellis RJ, Kolson DL, Simpson D, Nath A, Berger J, Shriver SL, et al. Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study. Aids (London, England). 21: 1877-86. PMID 17721095 DOI: 10.1097/Qad.0B013E32813384E8 |
0.478 |
|
| 2006 |
Schifitto G, Yiannoutsos CT, Simpson DM, Marra CM, Singer EJ, Kolson DL, Nath A, Berger JR, Navia B. A placebo-controlled study of memantine for the treatment of human immunodeficiency virus-associated sensory neuropathy. Journal of Neurovirology. 12: 328-31. PMID 16966223 DOI: 10.1080/13550280600873835 |
0.338 |
|
| 2006 |
Wools-Kaloustian K, Kimaiyo S, Diero L, Siika A, Sidle J, Yiannoutsos CT, Musick B, Einterz R, Fife KH, Tierney WM. Viability and effectiveness of large-scale HIV treatment initiatives in sub-Saharan Africa: experience from western Kenya. Aids (London, England). 20: 41-8. PMID 16327318 |
0.342 |
|
| 2005 |
Ellis RJ, Evans SR, Clifford DB, Moo LR, McArthur JC, Collier AC, Benson C, Bosch R, Simpson D, Yiannoutsos CT, Yang Y, Robertson K. Clinical validation of the NeuroScreen. Journal of Neurovirology. 11: 503-11. PMID 16338744 DOI: 10.1080/13550280500384966 |
0.367 |
|
| 2004 |
Chang L, Lee PL, Yiannoutsos CT, Ernst T, Marra CM, Richards T, Kolson D, Schifitto G, Jarvik JG, Miller EN, Lenkinski R, Gonzalez G, Navia BA. A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age. Neuroimage. 23: 1336-47. PMID 15589098 DOI: 10.1016/J.Neuroimage.2004.07.067 |
0.537 |
|
| 2004 |
Yiannoutsos CT, Ernst T, Chang L, Lee PL, Richards T, Marra CM, Meyerhoff DJ, Jarvik JG, Kolson D, Schifitto G, Ellis RJ, Swindells S, Simpson DM, Miller EN, Gonzalez RG, et al. Regional patterns of brain metabolites in AIDS dementia complex. Neuroimage. 23: 928-35. PMID 15528093 DOI: 10.1016/J.Neuroimage.2004.07.033 |
0.464 |
|
| 2003 |
Lee PL, Yiannoutsos CT, Ernst T, Chang L, Marra CM, Jarvik JG, Richards TL, Kwok EW, Kolson DL, Simpson D, Tang CY, Schifitto G, Ketonen LM, Meyerhoff DJ, Lenkinski RE, et al. A multi-center 1H MRS study of the AIDS dementia complex: validation and preliminary analysis. Journal of Magnetic Resonance Imaging : Jmri. 17: 625-33. PMID 12766890 DOI: 10.1002/Jmri.10295 |
0.407 |
|
| 2001 |
Simpson DM, Katzenstein D, Haidich B, Millington D, Yiannoutsos C, Schifitto G, McArthur J. Plasma carnitine in HIV-associated neuropathy. Aids (London, England). 15: 2207-8. PMID 11684949 DOI: 10.1097/00002030-200111090-00025 |
0.308 |
|
| 1999 |
Price RW, Yiannoutsos CT, Clifford DB, Zaborski L, Tselis A, Sidtis JJ, Cohen B, Hall CD, Erice A, Henry K. Neurological outcomes in late HIV infection: adverse impact of neurological impairment on survival and protective effect of antiviral therapy. AIDS Clinical Trial Group and Neurological AIDS Research Consortium study team. Aids (London, England). 13: 1677-85. PMID 10509569 DOI: 10.1097/00002030-199909100-00011 |
0.318 |
|
| 1999 |
Clifford DB, Yiannoutsos C, Glicksman M, Simpson DM, Singer EJ, Piliero PJ, Marra CM, Francis GS, McArthur JC, Tyler KL, Tselis AC, Hyslop NE. Haart improves prognosis in HIV-associated progressive multifocal leukoencephalopathy Neurology. 52: 623-625. PMID 10025799 DOI: 10.1212/Wnl.52.3.623 |
0.379 |
|
| 1998 |
Cinque P, Casari S, Bertelli D, Hall CD, Yiannoutsos C, Clifford DB. Progressive multifocal leukoencephalopathy, HIV, and highly active antiretroviral therapy [4] (multiple letters) New England Journal of Medicine. 339: 848-849. PMID 9750081 DOI: 10.1056/NEJM199809173391216 |
0.333 |
|
| 1998 |
Navia BA, Dafni U, Simpson D, Tucker T, Singer E, McArthur JC, Yiannoutsos C, Zaborski L, Lipton SA. A phase I/II trial of nimodipine for HIV-related neurologic complications. Neurology. 51: 221-8. PMID 9674806 DOI: 10.1212/Wnl.51.1.221 |
0.343 |
|
| Show low-probability matches. |